If the genome is the blueprint of life, epigenetics is the control system that determines when, where, and how genes are expressed. By revealing how chemical modifications to DNA and chromatin shape ...

Phase 1 dose-escalation trial on track; preclinical combination data with anti-PD-1 antibody demonstrates potential for ...

Among the many short peptides that have attracted sustained scientific curiosity, glycyl-L-histidyl-L-lysine complexed with ...

Interim clinical results for the BB-301 Phase 1b/2a study include 12-month post-treatment follow-up results for the first four Cohort 1 ...

Sheep vs. goats: Over 8,000 years, sheep developed greater variation in tooth size and shape, while goats remained more uniform, reflecting different breeding and use by humans. Fish under pressure: ...

A ripple tells you something happened, but not exactly what. That is the core problem behind a hard class of equations that ...

Global Immune Repertoire Sequencing Market OverviewThe global immune repertoire sequencing market is projected to expand at a steady compound annual growth rate of approximately 10% during the ...

Affinia Therapeutics (“Affinia”), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating ...

Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...

Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical Center. MIAMI, FL / ACCESS Newswire / April 30, 2026 / Telomir Pharmaceuticals, Inc. (N ...